Evidence map›Paper›PMID 33129424›Full record

ArticleThe Lancet. Infectious diseases2021

Incidence of influenza during pregnancy and association with pregnancy and perinatal outcomes in three middle-income countries: a multisite prospective longitudinal cohort study.

Fatimah S Dawood, Wanitchaya Kittikraisak, Archana Patel, Danielle Rentz Hunt, Piyarat Suntarattiwong, Meredith G Wesley, Mark G Thompson, Giselle Soto, Shailendra Mundhada, Carmen S Arriola and 19 more

Erratum issued Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in The Lancet. Infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06815250 (Effectiveness of the Influenza and Tdap), which is not on this map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06815250 narecruitingnot on this mapstarted 2026, after this paper: background citation

Effectiveness of the Influenza and Tdap (Tetanus, Diphtheria, Acellular Pertussis) Vaccination Educational and Learning Module (InTroDuce-Programme) in Improving Knowledge and Future Uptake of Vaccination Among Pregnant Mothers in Primary Care Clinics: A Randomised Control Trial Secondary IDs

TypeinterventionalSponsorUniversiti Putra MalaysiaRan2026 to 2026Enrolled351ConditionsVaccination Uptake, Knowledge, Tetanus, Diphtheria and Acellular Pertussis Vaccination, InfluenzaArmsInfluenza and Tdap Vaccination Educational and Learning Module
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. The added value of serologic testing: A comparison of influenza incidence among pregnant persons based on molecular-based surveillance versus serologic testing.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 12 institutions in 4 countries.

Fatimah S DawoodInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: fdawood@cdc.gov.
Wanitchaya KittikraisakThailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Archana PatelLata Medical Research Foundation, Nagpur, India; Datta Meghe Institute of Medical Sciences, Wardha, India.
Danielle Rentz HuntAbt Associates, Atlanta, GA, USA.
Piyarat SuntarattiwongQueen Sirikit National Institute of Child Health, Thailand Ministry of Public Health, Bangkok, Thailand.
Meredith G WesleyInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA; Abt Associates, Atlanta, GA, USA.
Mark G ThompsonInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Giselle SotoUS Naval Medical Research Unit No 6, Bellavista, Peru.
Shailendra MundhadaDhruv Pathology and Molecular Diagnostics Lab, Nagpur, India.
Carmen S ArriolaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Eduardo Azziz-BaumgartnerInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Tana BrummerAbt Associates, Atlanta, GA, USA.
Santiago CabreraHospital Nacional Docente Madre Niño San Bartolomé, Lima, Peru.
Howard H ChangRollins School of Public Health, Emory University, Atlanta, GA, USA.
Madhavi DeshmukhDhruv Pathology and Molecular Diagnostics Lab, Nagpur, India.
Damon EllisonArmed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Richard FlorianHospital Nacional Arzobispo Loayza, Lima, Peru.
Oswaldo GonzalesInstituto Nacional Materno Perinatal, Lima, Peru.
Kunal KurheLata Medical Research Foundation, Nagpur, India.
Surasak KaoieanRajavithi Hospital, Bangkok, Thailand.
Boonsong RawangbanNopparat Rajathanee Hospital, Bangkok, Thailand.
Stephen LindstromInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Edwin LlajarunaHospital Nacional Dos de Mayo, Lima, Peru.
Joshua A MottThailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Siddhartha SahaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Amber PrakashLata Medical Research Foundation, Nagpur, India.
Sarita MohantyInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Chalinthorn SinthuwattanawiboolThailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Yeny TinocoUS Naval Medical Research Unit No 6, Bellavista, Peru.
Centers for Disease Control and Prevention · USMinistry of Public Health · THLata Medical Research Foundation · INAbt Global (United States) · USInstituto Nacional de Salud del Niño · PENaval Medical Research Unit Six · PEArmed Forces Research Institute of Medical Science · THEmory University · USHospital Nacional Dos de Mayo · PENopparat Rajathanee Hospital · THRajavithi Hospital · THSchulman, Ronca & Bucuvalas · US

Funding

CGH CDC HHS U01 GH002084Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundInfluenza vaccination during pregnancy prevents influenza among women and their infants but remains underused among pregnant women. We aimed to quantify the risk of antenatal influenza and examine its association with perinatal outcomes.

methodsWe did a prospective cohort study in pregnant women in India, Peru, and Thailand. Before the 2017 and 2018 influenza seasons, we enrolled pregnant women aged 18 years or older with expected delivery dates 8 weeks or more after the season started. We contacted women twice weekly until the end of pregnancy to identify illnesses with symptoms of myalgia, cough, runny nose or nasal congestion, sore throat, or difficulty breathing and collected mid-turbinate nasal swabs from symptomatic women for influenza real-time RT-PCR testing. We assessed the association of antenatal influenza with preterm birth, late pregnancy loss (≥13 weeks gestation), small for gestational age (SGA), and birthweight of term singleton infants using Cox proportional hazards models or generalised linear models to adjust for potential confounders.

findingsBetween March 13, 2017, and Aug 3, 2018, we enrolled 11 277 women with a median age of 26 years (IQR 23-31) and gestational age of 19 weeks (14-24). 1474 (13%) received influenza vaccines. 310 participants (3%) had influenza (270 [87%] influenza A and 40 [13%] influenza B). Influenza incidences weighted by the population of women of childbearing age in each study country were 88·7 per 10 000 pregnant woman-months (95% CI 68·6 to 114·8) during the 2017 season and 69·6 per 10 000 pregnant woman-months (53·8 to 90·2) during the 2018 season. Antenatal influenza was not associated with preterm birth (adjusted hazard ratio [aHR] 1·4, 95% CI 0·9 to 2·0; p=0·096) or having an SGA infant (adjusted relative risk 1·0, 95% CI 0·8 to 1·3, p=0·97), but was associated with late pregnancy loss (aHR 10·7, 95% CI 4·3 to 27·0; p<0·0001) and reduction in mean birthweight of term, singleton infants (-55·3 g, 95% CI -109·3 to -1·4; p=0·0445).

interpretationWomen had a 0·7-0·9% risk of influenza per month of pregnancy during the influenza season, and antenatal influenza was associated with increased risk for some adverse pregnancy outcomes. These findings support the added value of antenatal influenza vaccination to improve perinatal outcomes.

fundingUS Centers for Disease Control and Prevention. TRANSLATIONS: For the Thai, Hindi, Marathi and Spanish translations of the abstract see Supplementary Materials section.

Indexed as

Infant, Small for Gestational AgeAdultCohort StudiesDeveloping CountriesFemaleHumansIncidenceIndiaInfant, NewbornInfluenza, HumanLongitudinal StudiesMalePeruPregnancyPregnancy Complications, InfectiousPregnancy Outcome

Identifiers

PMID33129424
PMCPMC10563867
OpenAlexW3094710232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.